WHO Is Cautious Of Favoring Plasma Therapy For COVID-19 Patients
WHO claims that the plasma therapy is at its nascent stage with no conclusive evidence of its success on covid19 patients
The World Health Organization (WHO) has raised concerns about endorsing plasma therapy as a solution for treating the novel Coronavirus. This comes just a day after the United States of America issued an emergency authorization of COVID19 plasma treatment.
According to the United Nations health body, the therapy that uses the plasma of recovered coronavirus patients to treat those who are positive, is more of an experimental treatment, as on today. They also stated that all studies and research around this subject are small and yield low quality results.
Chief Scientist of WHO, Soumya Swaminathan said that several clinical trials for the convalescent plasma therapy are being conducted by many companies across the globe. She elaborated that her organization is tracking all these developments with a systematic approach from time to time. Adding that a few have reported out the results, only some even pointed to benefits of the treatment, that too with mostly inconclusive evidence of its success.
While many countries around the world have already used this method to treat corona patients, experts are yet to corroborate its effectiveness and long-term benefits.
Catch all the latest trending news only ZEE5